Key facts
- This page summarizes Shubham Maheshwari's Form 4 filing for Varex Imaging Corp (VREX).
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 15 Sep 2026, 17:44.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Options Exercise
Sale
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Options Exercise
Additional SEC filing notes
Footnote F1
Includes 2,137 shares purchased under the Varex Imaging Corporation 2017 Employee Stock Purchase Plan since the last Form 4 filing of the reporting person.
Footnote F2
The sales reported on this Form 4 were effected pursuant to a broker-assisted sell-to-cover exercise of fully vested options. The shares were sold solely to cover the aggregate exercise price, applicable tax withholdings and broker's fees. The reporting person retained all remaining shares acquired upon exercise.
Footnote F3
The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.460 to $18.470. The reporting person undertakes to provide Varex Imaging Corporation, any security holder of Varex Imaging Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Footnote F4
These Performance Stock Options were subject to a four-year vesting schedule. 25% of the total number of options vested on August 15, 2021 and the remaining options vested monthly thereafter on a pro rata basis.